Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Instructions for Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Instructions for Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
netupitant, palonosetron, Akynzeo, Emend, Asians
Email alerts
netupitant, palonosetron, Akynzeo, Emend, Asians
NEPA efficacy and tolerability during (neo)adjuvant breast cancer chemotherapy with cyclophosphamide and doxorubicin
Winnie
Yeo
,
Thomas KH
Lau
,
Carol CH
Kwok
,
Kwai T
Lai
,
Vicky TC
Chan
,
Leung
Li
,
Vivian
Chan
,
Ashley
Wong
,
Winnie MT
Soo
,
Eva WM
Yeung
,
Kam H
Wong
,
Nelson LS
Tang
,
Joyce JS
Suen
,
Frankie KF
Mo
BMJ Supportive & Palliative Care
Jul 2022,
12
(e2)
e264-e270;
DOI:
10.1136/bmjspcare-2019-002037
CLINICAL
(8947)
NON-CLINICAL
(3136)
Special collections
Editor's choice
(26)
Guidelines, Recommendations and Consensus Statements
Open access
(114)
Press releases
(11)
